FLT3 and acute myeloid leukemia: AML is an aggressive malignancy characterized by abnormal proliferation of myeloid progenitor cells and is strongly associated with mutations in the FMS-like tyrosine kinase 3 (FLT3) gene or the abnormal fusion gene promyelocytic leukemia/retinoic acid receptor alpha (PML/RARA) [3,5].